Red Imported Fire Ant in Australia: What if we lose the war?

In Australia, a national eradication programme for the Red Imported Fire Ant (Solenopsis invicta Buren), one of the world's most invasive species, has been in operation since 2001 when the pest was first detected in Brisbane, Queensland. Since that time, four separate incursions of this ant have been successfully eradicated from this country, but the main Brisbane population remains. Cost-benefit analyses already conducted put the likely impact of Red Imported Fire Ant in Australia, if not eradicated, at between A$8.5 and A$45 billion. Despite this, ongoing funding for the eradication programme is not assured. A recent external review has concluded that it remains technically feasible, cost beneficial and in the national interest to eradicate. In support of previous analyses, our study highlights some of the potential impacts of Red Imported Fire Ant in Australia in more detail and provides case examples. Results show that adverse impacts are likely in most sectors of the economy, and will be felt not only by agricultural industries, but also the building and construction, tourism, electrical and communications industries. In addition to industry effects, there will also be negative impacts on public health and lifestyle, the environment and infrastructure such as main roads, airports and schools. Our estimates of potential cost impacts in the case examples where extrapolation was possible exceed A$1.65 billion/year and support previous predictions. We conclude that increased spending is justified to avert ‘invasion debt’ – the future cost of battling pests that escape today. This is a war that Australia cannot afford to lose

Does lumbar spinal degeneration begin with the anterior structures? A study of the observed epidemiology in a community-based population

<p>Abstract</p> <p>Background-</p> <p>Prior studies that have concluded that disk degeneration uniformly precedes facet degeneration have been based on convenience samples of individuals with low back pain. We conducted a study to examine whether the view that spinal degeneration begins with the anterior spinal structures is supported by epidemiologic observations of degeneration in a community-based population.</p> <p>Methods-</p> <p>361 participants from the Framingham Heart Study were included in this study. The prevalences of anterior vertebral structure degeneration (disk height loss) and posterior vertebral structure degeneration (facet joint osteoarthritis) were characterized by CT imaging. The cohort was divided into the structural subgroups of participants with 1) no degeneration, 2) isolated anterior degeneration (without posterior degeneration), 3) combined anterior and posterior degeneration, and 4) isolated posterior degeneration (without anterior structure degeneration). We determined the prevalence of each degeneration pattern by age group < 45, 45-54, 55-64, ≥65. In multivariate analyses we examined the association between disk height loss and the response variable of facet joint osteoarthritis, while adjusting for age, sex, BMI, and smoking.</p> <p>Results-</p> <p>As the prevalence of the no degeneration and isolated anterior degeneration patterns decreased with increasing age group, the prevalence of the combined anterior/posterior degeneration pattern increased. 22% of individuals demonstrated isolated posterior degeneration, without an increase in prevalence by age group. Isolated posterior degeneration was most common at the L5-S1 and L4-L5 spinal levels. In multivariate analyses, disk height loss was independently associated with facet joint osteoarthritis, as were increased age (years), female sex, and increased BMI (kg/m²), but not smoking.</p> <p>Conclusions-</p> <p>The observed epidemiology of lumbar spinal degeneration in the community-based population is consistent with an ordered progression beginning in the anterior structures, for the majority of individuals. However, some individuals demonstrate atypical patterns of degeneration, beginning in the posterior joints. Increased age and BMI, and female sex may be related to the occurrence of isolated posterior degeneration in these individuals.</p

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS: During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS: Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)

Invasive ants in Australia: documented and potential ecological consequences

A growing number of species are being transported and introduced by humans to new locations and are establishing self-sustaining populations outside their native ranges. Since ants play many ecological roles, introduction of an invasive ant species, and subsequent disruption of Australia's rich and abundant native ant fauna, has the potential for numerous adverse consequences. Over 6700 ants representing 105 species from 73 genera have been intercepted at Australian ports of entry in the last 20 years and all six of the world's most destructive invasive ants have become established in the country. Here we review the current and potential consequences of these ants on Australia's natural and agricultural environments. To date, several studies, most involving the big-headed ant, Pheidole megacephala, and the Argentine ant, Linepithema humile, have documented a decline in native ant species richness. The displacement of native ants by these invaders could have multiple consequences for the native flora and fauna. Since few of these have been investigated in Australia, we combine knowledge from invasions elsewhere, the ecology of the interactions, and data on current and predicted geographic ranges of introduced ants to hypothesise about likely indirect effects of invasive ants in Australia. Further investigations that are aimed at testing these predictions will also aid in justifying and prioritising national prevention and control efforts, and will contribute to some of the long-standing questions about ant invasions globally